Pharmacyte Biotech Inc. (PMCB)
NASDAQ · Healthcare
Pharmacyte Biotech Inc. Price to Book Ratio 2013–2026
Price to book (P/B) ratio for Pharmacyte Biotech Inc. (PMCB): market cap divided by shareholder equity. As of January 31, 2026 it is 0.15.
From: 07/31/2011To: 01/31/2026
Stock Price
Book Value
Price to Book
Pharmacyte Biotech Inc. Price to Book Ratio — FAQ
Pharmacyte Biotech Inc. (PMCB) price to book ratio over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PMCB's price to book ratio history?
The chart and table above show Pharmacyte Biotech Inc.'s price to book ratio by year and by quarter, including the growth rate.